Almitrine
- Generic Name
- Almitrine
- Drug Type
- Small Molecule
- Chemical Formula
- C26H29F2N7
- CAS Number
- 27469-53-0
- Unique Ingredient Identifier
- 9A1222NBG4
Overview
Almitrine is a respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. It is used in the treatment of chronic obstructive pulmonary disease. It is also reported to have a potentially beneficial effect in treating the noctural oxygen desaturation without impairing the quality of sleep.
Background
Almitrine is a respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. It is used in the treatment of chronic obstructive pulmonary disease. It is also reported to have a potentially beneficial effect in treating the noctural oxygen desaturation without impairing the quality of sleep.
Indication
For the treatment of chronic obstructive pulmonary disease.
Associated Conditions
- Age-associated Cognitive Impairment
- Dizziness
- Neurological Disorders
- Respiratory Insufficiency
- Respiratory Insufficiency caused by Chronic Bronchitis
- Visual Impairment
- Hearing loss or impairment
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.